SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL | ||||
Journal of the Egyptian Society of Parasitology | ||||
Article 15, Volume 51, Issue 2, August 2021, Page 365-370 PDF (739.87 K) | ||||
Document Type: Original Article | ||||
DOI: 10.21608/jesp.2021.193317 | ||||
View on SCiNiTO | ||||
Authors | ||||
SALWA M. MORSY1; MOUSA A. M. ISMAIL1; MARWA M. I. GHALLAB2 | ||||
1Department of Medical Parasitology, Faculty of Medicine, Cairo University | ||||
2Department of Medical Parasitology, Faculty of Medicine, Kafrelsheikh University, Egypt | ||||
Abstract | ||||
Several studies demonstrated a high seroprevalence of Toxoplasma gondii in schizophrenic patients than healthy individuals. This case control study determined the serprevalence of T. gondii among schizophrenic patients and healthy individuals at Kafrelsheikh University Hospitals and to estimate its effect on serum dopamine level. T. gondii IgG was detected in 52.2% &23.9% of schizophrenic patients and healthy individuals respectively with significance (P value = 0.005). Serum dopamine level was higher in schizophrenic patients than healthy individuals with statistical significance (P = <0.001) and also higher in T. gondii IgG positive than T. gondii IgG negative patients with statistical significance (P = <0.001). | ||||
Keywords | ||||
Toxoplasma gondii; Schizophrenic Non-schizophrenic; Dopamine level | ||||
Statistics Article View: 151 PDF Download: 236 |
||||